Other Trials

Other Cancer Clinical Trials

Protocol
Number

Title

ID

Par
Pharmaceuticals
EVE01-SV-1301
2013-63
A randomized, Open- Label, 2 Way Crossover Study of the Bioequivalence of Everolimus 10-mg Tablets in Patients Receiving Afinitor ® for the Teatment of Cancer.  
Merck
Vaccine
V212

A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy

Learn more.

NCT01254630
Prometheus
Proclaim
10PLK 13

Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Learn more.

NCT01415167